This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Del Rio RA, Post AB, Singer ME.Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy. Hepatology 44: 1598-1606, No. 6, Dec 2006
Muir AJ, McHutchison JG.Growth factors during HCV therapy may be cost-effective, but are they effective? Hepatology 44: 1400-1403, No. 6, Dec 2006
Rights and permissions
About this article
Cite this article
Darbepoetin alfa worth it for anaemia in HCV. Pharmacoecon. Outcomes News 521, 4 (2007). https://doi.org/10.2165/00151234-200705210-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00012